Structure-based HIV-1 integrase inhibitor design: a future perspective

By Neamati N.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 281-296

Informa Healthcare

Access to resources Recommend Favorite

Structure-Based Inhibitor Design Targeting HIV-1 Integrase

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 217-234

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Design of Conformationally Flexible Reverse Transcriptase Inhibitors to Combat Resistant HIV

By  

Current Pharmaceutical Design, Vol. 20, Iss. 5, 2014-02 ,pp. : 725-739

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Recombinant DNA Technology and Protein Engineering on Structure-Based Drug Design: Case Studies of HIV-1 and HCMV Proteases

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-03 ,pp. : 247-269

Bentham Science Publishers

Access to resources Recommend Favorite